Molecular Oncology Training Program

分子肿瘤学培训计划

基本信息

  • 批准号:
    9316338
  • 负责人:
  • 金额:
    $ 16.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-18 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This is a new proposal to establish a training program at Columbia University focused on training physicians in research techniques that will form the basis of careers in translational investigation of cancer biology, diagnosis and treatment. We will identify and recruit individuals with outstanding research potential who have completed clinical training in medical oncology and prepare them for productive careers as translational investigators in oncology. We will utilize a comprehensive two-year program comprised of didactics, workshops, small group sessions, coursework, including a possible master's degree, and individualized training within the research programs of Columbia University faculty to develop the careers of the participants. Funds are requested in a graded fashion to support up to 4 trainees annually. The Molecular Oncology Training Program faculty is comprised of 26 independent investigators who will provide direct supervision of the trainees. The faculty members are uniformly funded by the NCI, other branches of the NIH and other cancer-focused research organizations and have established themselves as thought-leaders in a broad range of cancer-related disciplines. Participating faculty have been identified on the basis of their research productivity and quality, demonstrated collaboration with other investigators, often across research disciplines, and a history of supporting and developing research careers that transition beyond the post-doctoral level. The trainees will be chosen competitively from a highly select group of committed physician researchers on the basis of past accomplishments and their potential to develop careers as productive, independent translational investigators. The Molecular Oncology Training Program will be supported by the diverse research resources at Columbia University and the ongoing expansion and commitment to oncology that has included both laboratory and clinically focused research. The expansion was heralded by the opening of the Irving Cancer Research Center a 300,000 square-foot building within the Columbia University Medical Center that is entirely dedicated to cancer research and the ongoing recruitment of leading clinical-translational research faculty to the Division of Hematology and Medical Oncology. These changes have significantly broadened the diversity of research at Columbia University with a concomitant increase in quality that has established Columbia in the top tier of oncology programs and has attracted a pool of consummately trained physicians committed to careers in translational cancer biology.
 描述(由申请人提供):这是一项在哥伦比亚大学建立培训计划的新提议,重点是培训医生的研究技术,这些技术将成为癌症生物学、诊断和治疗转化研究的职业基础。我们将 识别和招募具有杰出研究潜力的个人,他们已经完成了医学肿瘤学的临床培训,并为他们作为肿瘤学翻译研究者的生产性职业做好准备。我们将利用一个全面的为期两年的计划,包括教学法,研讨会,小组会议,课程,包括可能的硕士学位,并在哥伦比亚大学教师的研究计划个性化的培训,以发展参与者的职业生涯。资金是分等级申请的,每年最多可支助4名受训人员。 分子肿瘤学培训计划教师由26名独立研究人员组成,他们将直接监督学员。教师由NCI,NIH的其他分支机构和其他以癌症为重点的研究组织统一资助,并已成为广泛的癌症相关学科的思想领袖。参与的教师是根据他们的研究生产力和质量确定的, 展示了与其他研究人员的合作,通常是跨学科的,以及支持和发展超越博士后水平的研究职业的历史。学员将根据过去的成就和他们作为富有成效的独立翻译研究者发展事业的潜力,从一群高度精选的致力于医生研究人员中进行竞争性选择。 分子肿瘤学培训计划将得到哥伦比亚大学多样化研究资源的支持,以及对肿瘤学的持续扩展和承诺,包括实验室和临床重点研究。扩张是由欧文癌症研究中心的开放,一个30万平方英尺的建筑内的哥伦比亚大学医学中心,完全致力于癌症研究和领先的临床转化研究教师的血液学和医学肿瘤学的部门正在招聘预示。这些变化显着扩大了哥伦比亚大学的研究多样性,同时提高了质量,确立了哥伦比亚在肿瘤学项目的顶级地位,并吸引了一批受过消费培训的医生致力于转化癌症生物学的职业生涯。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAWN HERSHMAN其他文献

DAWN HERSHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAWN HERSHMAN', 18)}}的其他基金

Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and Reduce Refill Rates after Cancer Surgery
药丸分配系统在增加未使用阿片类药物的处置并降低癌症手术后补充率方面的功效
  • 批准号:
    10665967
  • 财政年份:
    2023
  • 资助金额:
    $ 16.02万
  • 项目类别:
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
公平地提高依从性的干预(影响试验)
  • 批准号:
    10657754
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
公平地提高依从性的干预(影响试验)
  • 批准号:
    10437181
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
公平地提高依从性的干预(影响试验)
  • 批准号:
    10494225
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10933782
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
  • 批准号:
    9975367
  • 财政年份:
    2020
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10089670
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
A randomized trial of topical menthol for chemotherapy induced neuropathy
局部薄荷醇治疗化疗引起的神经病变的随机试验
  • 批准号:
    8759581
  • 财政年份:
    2014
  • 资助金额:
    $ 16.02万
  • 项目类别:
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
使用 SWOG-Medicare 数据库评估癌症幸存者的长期毒性
  • 批准号:
    8620619
  • 财政年份:
    2013
  • 资助金额:
    $ 16.02万
  • 项目类别:
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
使用 SWOG-Medicare 数据库评估癌症幸存者的长期毒性
  • 批准号:
    8997455
  • 财政年份:
    2013
  • 资助金额:
    $ 16.02万
  • 项目类别:

相似海外基金

VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
  • 批准号:
    10225434
  • 财政年份:
    2018
  • 资助金额:
    $ 16.02万
  • 项目类别:
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
  • 批准号:
    9981681
  • 财政年份:
    2018
  • 资助金额:
    $ 16.02万
  • 项目类别:
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
  • 批准号:
    10449242
  • 财政年份:
    2018
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10449197
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    9074112
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10657666
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10089670
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Translating advances in molecular oncology into improved care for patients with haematological malignancies
将分子肿瘤学的进步转化为改善血液恶性肿瘤患者的护理
  • 批准号:
    nhmrc : 1079560
  • 财政年份:
    2015
  • 资助金额:
    $ 16.02万
  • 项目类别:
    Practitioner Fellowships
Translating advances in molecular oncology into improved care for patients with haematological malignancies
将分子肿瘤学的进步转化为改善血液恶性肿瘤患者的护理
  • 批准号:
    nhmrc : GNT1079560
  • 财政年份:
    2015
  • 资助金额:
    $ 16.02万
  • 项目类别:
    Practitioner Fellowships
MOLECULAR ONCOLOGY RESOURCE
分子肿瘤学资源
  • 批准号:
    8728584
  • 财政年份:
    2014
  • 资助金额:
    $ 16.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了